Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.
Clinical trial NCT05024253 · COMPLETED
Trial details
- NCT number
- NCT05024253
- Sponsor
- Children's Cancer Hospital Egypt 57357
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-02
- Primary completion
- 2024-02-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.